Tick bite sufferers may get relief from mast cell drugs
NCT ID NCT07526558
First seen Apr 21, 2026 · Last updated May 03, 2026 · Updated 3 times
Summary
This study tests whether two mast cell stabilizing medications, ketotifen and cromolyn, can safely reduce persistent symptoms in people who had a tick-borne illness like Ehrlichiosis or Rocky Mountain Spotted Fever. About 50 adults aged 21-65 will receive either the study drugs or standard care with fexofenadine. The goal is to see if these drugs improve symptom scores and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TICK BITE ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.